Holen Sie sich die Stockscreener-App
8.00
4.02%
-0.335
Schlusskurs vom Vortag:
$8.335
Offen:
$8.36
24-Stunden-Volumen:
64,787
Relative Volume:
0.70
Marktkapitalisierung:
$138.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.82M
KGV:
-0.3126
EPS:
-25.5891
Netto-Cashflow:
$-66.04M
1W Leistung:
-14.53%
1M Leistung:
-12.38%
6M Leistung:
+7.10%
1J Leistung:
+66.32%
1-Tages-Spanne:
$7.92
$8.445
1-Wochen-Bereich:
$7.43
$9.3784
52-Wochen-Spanne:
$4.60
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Firmenname
Elicio Therapeutics Inc
Sektor
Branche
Telefon
(857) 209-0050
Adresse
451 D STREET, 5TH FLOOR, BOSTON
Vergleichen Sie ELTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
8.00 | 143.68M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.09 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.34 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.69 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
902.61 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.69 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten
Pancreatic Ductal Adenocarcinoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Elicio Therapeutics, Cend Therapeutics, Silenseed, Amplia - Barchart.com
How Elicio Therapeutics Inc. (9HA) stock reacts to stronger dollarQuarterly Market Summary & Safe Capital Allocation Plans - Newser
How Elicio Therapeutics Inc. (9HA) stock reacts to new regulations2025 Winners & Losers & Long-Term Growth Plans - Newser
Will Elicio Therapeutics Inc. (9HA) stock benefit from mergersTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Avoiding Lag: Real-Time Signals in (ELTX) Movement - news.stocktradersdaily.com
Can Elicio Therapeutics Inc. stock deliver surprise earnings beat2025 Volatility Report & Real-Time Buy Zone Alerts - Newser
Can Elicio Therapeutics Inc. (9HA) stock sustain margin levelsAnalyst Downgrade & Safe Capital Growth Plans - Newser
Will Elicio Therapeutics Inc. stock benefit from AI adoptionWeekly Stock Recap & Weekly Stock Performance Updates - Newser
How Elicio Therapeutics Inc. (9HA) stock trades in high volatilityWeekly Trade Recap & Weekly Return Optimization Alerts - Newser
Is Elicio Therapeutics Inc. (9HA) stock undervalued historicallyTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Will Elicio Therapeutics Inc. (9HA) stock split increase liquidity2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
How Elicio Therapeutics Inc. (9HA) stock compares with top peers - Newser
Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025 - MSN
Discipline and Rules-Based Execution in ELTX Response - news.stocktradersdaily.com
Can Elicio Therapeutics Inc. (9HA) stock sustain breakout momentumQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Is Elicio Therapeutics Inc. stock a smart buy before Fed meeting2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Why Elicio Therapeutics Inc. (9HA) stock remains stableProfit Target & Consistent Return Investment Signals - newser.com
How Elicio Therapeutics Inc. stock performs in weak economyJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Can Elicio Therapeutics Inc. stock maintain operating marginsQuarterly Growth Report & Stock Timing and Entry Methods - newser.com
Retail investors are Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) biggest owners and were hit after market cap dropped US$8.5m - simplywall.st
How Elicio Therapeutics Inc. (9HA) stock performs during market turbulenceJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - newser.com
Can Elicio Therapeutics Inc. stock outperform in 2025 bull market2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
How high can Elicio Therapeutics Inc. stock goJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer By Investing.com - Investing.com Nigeria
Elicio Therapeutics Inc. stock trendline breakdownTrade Entry Summary & Low Volatility Stock Suggestions - newser.com
What earnings revisions data tells us about Elicio Therapeutics Inc.Trade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
Elicio Therapeutics, Inc. Appoints Marc J. Wolfgang, M.S. as Chief Technology Officer - MarketScreener
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer - Investing.com India
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer - The Manila Times
Elicio Therapeutics Appoints Veteran CMC and Technical - GlobeNewswire
Will Elicio Therapeutics Inc. outperform the marketPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):